| The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice |
82 |
| The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies |
66 |
| Migraine Progression: A Systematic Review |
42 |
| CGRP and the Trigeminal System in Migraine |
35 |
| A Phase-by-Phase Review of Migraine Pathophysiology |
33 |
| History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment |
23 |
| Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States |
23 |
| Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science |
21 |
| Sleep Disorders and Migraine: Review of Literature and Potential Pathophysiology Mechanisms |
21 |
| Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class |
21 |
| The Spectrum of Vestibular Migraine: Clinical Features, Triggers, and Examination Findings |
18 |
| Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences |
18 |
| Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine |
18 |
| The CGRP Pathway in Migraine as a Viable Target for Therapies |
18 |
| Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study |
17 |
| Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial |
17 |
| Spontaneous Intracranial Hypotension: 10 Myths and Misperceptions |
16 |
| Migraine Burden of Disease: From the Patient's Experience to a Socio-Economic View |
16 |
| A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina |
14 |
| Barriers to Behavioral Treatment Adherence for Headache: An Examination of Attitudes, Beliefs, and Psychiatric Factors |
14 |
| Tension-Type Headache - The Normal and Most Prevalent Headache |
14 |
| Hypercoagulability and Migraine |
13 |
| Anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018 |
13 |
| Transcranial Magnetic and Direct Current Stimulation (TMS/tDCS) for the Treatment of Headache: A Systematic Review |
13 |
| Identifying Natural Subgroups of Migraine Based on Comorbidity and Concomitant Condition Profiles: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study |
12 |
| Clinical Features, Familial History, and Migraine Precursors in Patients With Definite Vestibular Migraine: The VM-Phenotypes Projects |
12 |
| CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study |
11 |
| Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials |
10 |
| Does Mindfulness-Based Cognitive Therapy for Migraine Reduce Migraine-Related Disability in People with Episodic and Chronic Migraine? A Phase 2b Pilot Randomized Clinical Trial |
10 |
| Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study |
10 |
| Sleep Disorders Among People With Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study |
10 |
| Posttraumatic Headache: Classification by Symptom-Based Clinical Profiles |
10 |
| Novel Medications for the Treatment of Migraine |
9 |
| 100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase Randomized, Double-Blind, Placebo-Controlled EVOLVE-1 and EVOLVE-2 Studies |
9 |
| Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review |
9 |
| Effects of Non-invasive Brain Stimulation on Headache Intensity and Frequency of Headache Attacks in Patients With Migraine: A Systematic Review and Meta-Analysis |
8 |
| Levcromakalim, an Adenosine Triphosphate-Sensitive Potassium Channel Opener, Dilates Extracerebral but not Cerebral Arteries |
8 |
| FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine |
8 |
| Risk of Stroke Associated With Use of Estrogen Containing Contraceptives in Women With Migraine: A Systematic Review |
8 |
| Less Cortical Thickness in Patients With Persistent Post-Traumatic Headache Compared With Healthy Controls: An MRI Study |
8 |
| Sleep and Migraine: Assessment and Treatment of Comorbid Sleep Disorders |
8 |
| Concussion: A History of Science and Medicine, 1870-2005 |
8 |
| Antagonistic Relationship Between VEP Potentiation and Gamma Power in Visual Snow Syndrome |
8 |
| Histamine and Migraine |
8 |
| The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post-Hoc Analyses on the First 3 Weeks of Treatment |
8 |
| Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study |
8 |
| Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies |
8 |
| Cerebral Venous Thrombosis in Spontaneous Intracranial Hypotension: A Report on 4 Cases and a Review of the Literature |
8 |
| The Clinical Characteristics and Neurophysiological Assessments of the Occipital Cortex in Visual Snow Syndrome With or Without Migraine |
7 |
| Getting to the Heart of the Matter: Migraine, Triptans, DHE, Ditans, CGRP Antibodies, First/Second-Generation Gepants, and Cardiovascular Risk |
7 |
